Head of Discovery Chemistry and Molecular Technologies
Percy Carter is the Head of Discovery Chemistry and Molecular Technologies at Bristol-Myers Squibb. There he founded the Discovery Chemistry Platforms Group, which uses technology both to enhance efficiency and to expand the boundaries of traditional medicinal chemistry.
He has been with BMS since 2001 when they acquired DuPont Pharmaceuticals where he was a Senior Research Scientist in Chemical and Physical Sciences.
In this time with Bristol-Myers Squibb, Percy a leadership award within R&D for work done in Immunology Chemistry and a company-wide leadership award.
Percy received his PhD in Organic Chemistry from Harvard University, and completed a post-doctoral fellowship at Harvard Medical School and Massachusetts General Hospital. In 2014 he received his MBA from the Massachusetts Institute of Technology.
Percy is the inventor or co-inventor on 28 U.S. Patents and has authored or co-authored more than 50 peer-reviewed research publications.